Drug Profile
Pneumococcal vaccine protein-based - Sanofi pasteur
Alternative Names: Pneumococcal vaccine - Provalis/SanofiLatest Information Update: 08 Apr 2022
Price :
$50
*
At a glance
- Originator Provalis
- Developer Sanofi
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pneumococcal-infections in Bangladesh (Parenteral)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pneumococcal-infections in Switzerland (Parenteral)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pneumococcal-infections(In infants) in France (Parenteral)